Feb 26, 2026 08:00AM
Feb 10, 2026 08:03AM
Feb 10, 2026 08:00AM
Feb 3, 2026 08:00AM
Jan 26, 2026 08:02AM
Jan 26, 2026 08:00AM
Jan 13, 2026 06:09AM Milestone Pharmaceuticals receives $75 million from RTW for etripamil royalties
Jan 6, 2026 08:02AM
Jan 6, 2026 08:00AM
Dec 21, 2025 04:00AM
Dec 17, 2025 05:00PM
Dec 17, 2025 05:00PM
Dec 15, 2025 10:03AM
Dec 12, 2025 08:00PM Milestone Pharmaceuticals wins FDA approval for nasal spray heart drug
Dec 12, 2025 08:00PM
Nov 12, 2025 07:01AM
Nov 4, 2025 04:05PM
Nov 3, 2025 08:00AM
Oct 9, 2025 08:00AM
Aug 19, 2025 08:00AM
Aug 12, 2025 07:05AM Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
Jul 11, 2025 09:32AM
Jul 11, 2025 09:30AM
Jul 11, 2025 06:02AM
Jul 11, 2025 06:01AM
Jul 11, 2025 06:00AM
Jul 11, 2025 06:00AM
Jun 17, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
Jun 16, 2025 08:03AM
Jun 16, 2025 08:00AM
May 14, 2025 07:04AM
Apr 10, 2025 08:30AM
Apr 1, 2025 06:13AM
Mar 28, 2025 07:00AM
Mar 28, 2025 07:00AM FDA Issues Complete Response Letter for Etripamil for PSVT
Mar 20, 2025 08:00AM
Mar 18, 2025 06:44AM
Mar 13, 2025 07:08AM
Feb 19, 2025 08:01AM
Feb 19, 2025 08:00AM
Feb 11, 2025 08:00AM
Jan 28, 2025 08:04AM Milestone Pharmaceuticals (MIST) Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
Jan 28, 2025 08:00AM
Jan 27, 2025 07:23AM
Nov 12, 2024 09:03AM
Sep 6, 2024 07:01AM
Sep 6, 2024 07:00AM
Sep 4, 2024 08:03AM
Sep 4, 2024 08:00AM Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
Aug 8, 2024 04:17PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All